Foundation Medicine, Inc.
FMI
FMI was delisted on the 30th of July, 2018.
85 hedge funds and large institutions have $443M invested in Foundation Medicine, Inc. in 2013 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 9 closing their positions.
825% more capital invested
Capital invested by funds: $47.9M → $443M (+$396M)
756% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 9
400% more funds holding
Funds holding: 17 → 85 (+68)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$54.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$46.7M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.2M |
| 4 |
PG
PEAK6 Group
Chicago,
Illinois
|
+$11.1M |
| 5 |
DM
Deerfield Management
New York
|
+$9.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14M |
| 2 |
PC
Pier Capital
Stamford,
Connecticut
|
-$6.35M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.18M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.53M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$1.98M |
FMI Hedge Fund Activity: Q4 2013 in Review
85 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2013, worth a combined $443M — up 825% from $47.9M a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new FMI positions and 9 closed out — a net gain of 68 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $54.4M. The largest seller was Citadel Advisors, cutting an estimated $14M.
- 85 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2013, up from 17 in Q3 2013.
- Funds reported $443M of Foundation Medicine, Inc. stock for Q4 2013, up 825% quarter-over-quarter.
- 77 funds opened new Foundation Medicine, Inc. positions in Q4 2013 and 9 closed out, a net change of +68 holders.
- The largest Foundation Medicine, Inc. buyer in Q4 2013 was Gilder Gagnon Howe & Co, an estimated $54.4M added.
- The largest Foundation Medicine, Inc. seller in Q4 2013 was Citadel Advisors, an estimated $14M sold.
Based on aggregated 13F filings for Q4 2013.